chartexchange

LTRN
Lantern Pharma Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 2:25:00 PM EST
0.33USD-8.904%(-0.03)307,859
Pre-marketNov 18, 2026 9:27:30 AM EST
0.3512USD-3.781%(-0.0138)
After-hoursNov 18, 2026 4:21:30 PM EST
0.32USD-3.759%(-0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Dallas, TX, USA
Previous Close
$0.37
Beta
2.92
52-Week High
$4.34 2026-07-01
52-Week Low
$0.32 2026-11-18
SMA 50
$0.90
SMA 200
$2.28
Avg. Vol 10D
184,351
Avg. Vol 30D
250,924
Avg. Vol 90D
204,120
Relative Vol
1.23
10.69M
1.8200%
102
LTRN Profile

lantern pharma is leading a wave of innovation in cancer treatment that we believe will bring the best therapies to patients who are most likely to respond. we are pioneering precision medicine approach to cancer by tailoring promising drug programs to the right patients. our approach is to use biomarker based genetic screening to identify and treat patients that would benefit most from our drugs. we believe this approach will reduce the cost of development and increase the speed to market. our strategy is to acquire or partner with promising drug and diagnostic companies to move forward promising personalized medicine programs for cancer patients.

LTRN Performance
PeriodPriceDateChangeBeta
1W0.462026-11-12-29.42%1.209
1M0.642026-10-19-49.31%3.037
3M2.492026-08-19-86.94%2.131
6M3.092026-05-19-89.48%2.020
1Y3.272025-11-19-90.06%2.915
2Y3.082024-11-19-89.44%—
5Y8.992021-11-19-96.38%1.395
LTRN Stock Summary

Lantern Pharma Inc. Common Stock (NASDAQ:LTRN) stock price today is $0.33, and today's volume is 307,859. LTRN is down 10.932% today. The 30 day average volume is 250,924. LTRN market cap is $4.86M with 14.94M shares outstanding.